Cargando…
Identification of key genes in osteosarcoma – before and after CDK7 treatment
BACKGROUND: Osteosarcoma is one of the most common bone tumors, with a high degree of malignancy and a poor prognosis. Recent studies have shown that THZ2, a cyclin-dependent kinase 7 inhibitor, can exhibit strong antibone tumor effects in vivo and in vitro by inhibiting transcriptional activity. In...
Autores principales: | An, Yang, Wang, Yuanlin, Xu, Guoyong, Liao, Yinan, Huang, Ge, Jin, Xin, Xie, Chengxin, Li, Qinglong, Yin, Dong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8483848/ https://www.ncbi.nlm.nih.gov/pubmed/34596127 http://dx.doi.org/10.1097/MD.0000000000027304 |
Ejemplares similares
-
Prognostic factors and nomogram for the overall survival of bladder cancer bone metastasis: A SEER-based study
por: Huang, Yu, et al.
Publicado: (2023) -
Identification of key biomarkers and functional pathways in osteosarcomas with lung metastasis: Evidence from bioinformatics analysis
por: Liu, Denghua, et al.
Publicado: (2021) -
Gene expression profile and bioinformatics analysis revealed key molecular characteristics of chordoma—before and after TNF- a treatment
por: Xu, Guoyong, et al.
Publicado: (2020) -
Establishment of immune prognostic signature and analysis of prospective molecular mechanisms in childhood osteosarcoma patients
por: Zhang, Zide, et al.
Publicado: (2020) -
A five ferroptosis-related genes risk score for prognostic prediction of osteosarcoma
por: Ge, Zhanyong, et al.
Publicado: (2022)